712 related articles for article (PubMed ID: 17200412)
1. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.
Lahl K; Loddenkemper C; Drouin C; Freyer J; Arnason J; Eberl G; Hamann A; Wagner H; Huehn J; Sparwasser T
J Exp Med; 2007 Jan; 204(1):57-63. PubMed ID: 17200412
[TBL] [Abstract][Full Text] [Related]
2. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.
Lahl K; Mayer CT; Bopp T; Huehn J; Loddenkemper C; Eberl G; Wirnsberger G; Dornmair K; Geffers R; Schmitt E; Buer J; Sparwasser T
J Immunol; 2009 Nov; 183(9):5662-72. PubMed ID: 19812199
[TBL] [Abstract][Full Text] [Related]
3. Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras.
Komatsu N; Hori S
Proc Natl Acad Sci U S A; 2007 May; 104(21):8959-64. PubMed ID: 17494743
[TBL] [Abstract][Full Text] [Related]
4. Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth.
Teng MW; Ngiow SF; von Scheidt B; McLaughlin N; Sparwasser T; Smyth MJ
Cancer Res; 2010 Oct; 70(20):7800-9. PubMed ID: 20924111
[TBL] [Abstract][Full Text] [Related]
5. Limited role of CD4+Foxp3+ regulatory T cells in the control of experimental cerebral malaria.
Steeg C; Adler G; Sparwasser T; Fleischer B; Jacobs T
J Immunol; 2009 Dec; 183(11):7014-22. PubMed ID: 19890049
[TBL] [Abstract][Full Text] [Related]
6. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
[TBL] [Abstract][Full Text] [Related]
7. Few Foxp3⁺ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity.
Mayer CT; Ghorbani P; Kühl AA; Stüve P; Hegemann M; Berod L; Gershwin ME; Sparwasser T
Eur J Immunol; 2014 Oct; 44(10):2990-3002. PubMed ID: 25042334
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis.
Lo Re S; Lecocq M; Uwambayinema F; Yakoub Y; Delos M; Demoulin JB; Lucas S; Sparwasser T; Renauld JC; Lison D; Huaux F
Am J Respir Crit Care Med; 2011 Dec; 184(11):1270-81. PubMed ID: 21868503
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
Wan YY; Flavell RA
Nature; 2007 Feb; 445(7129):766-70. PubMed ID: 17220876
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression.
Peterson RA
Toxicol Pathol; 2012; 40(2):186-204. PubMed ID: 22222887
[TBL] [Abstract][Full Text] [Related]
14. Repeated Long-Term DT Application in the DEREG Mouse Induces a Neutralizing Anti-DT Antibody Response.
Wang J; Siffert M; Spiliotis M; Gottstein B
J Immunol Res; 2016; 2016():1450398. PubMed ID: 28074191
[TBL] [Abstract][Full Text] [Related]
15. Lack of Foxp3 function and expression in the thymic epithelium.
Liston A; Farr AG; Chen Z; Benoist C; Mathis D; Manley NR; Rudensky AY
J Exp Med; 2007 Mar; 204(3):475-80. PubMed ID: 17353370
[TBL] [Abstract][Full Text] [Related]
16. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.
Christiaansen AF; Boggiatto PM; Varga SM
J Immunol Methods; 2014 Apr; 406():58-65. PubMed ID: 24642426
[TBL] [Abstract][Full Text] [Related]
17. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.
Hsieh CS; Zheng Y; Liang Y; Fontenot JD; Rudensky AY
Nat Immunol; 2006 Apr; 7(4):401-10. PubMed ID: 16532000
[TBL] [Abstract][Full Text] [Related]
18. Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease.
Chikuma S; Bluestone JA
Eur J Immunol; 2007 May; 37(5):1285-9. PubMed ID: 17429849
[TBL] [Abstract][Full Text] [Related]
19. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
Beyer M; Schultze JL
Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
[TBL] [Abstract][Full Text] [Related]
20. In vivo depletion of FoxP3+ Tregs using the DEREG mouse model.
Lahl K; Sparwasser T
Methods Mol Biol; 2011; 707():157-72. PubMed ID: 21287334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
